You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 23, 2025

Details for Patent: 10,258,630


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,258,630
Title:Vaginal inserted estradiol pharmaceutical compositions and methods
Abstract: In one aspect, compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided. In one embodiment, the method comprises administering an estrogen to a subject having VVA by inserting a dosage form comprising a liquid pharmaceutical composition.
Inventor(s): Mirkin; Sebastian (Boca Raton, FL), Amadio; Julia M. (Boca Raton, FL), Bernick; Brian A. (Boca Raton, FL)
Assignee: TherapeuticsMD, Inc. (Boca Raton, FL)
Application Number:15/893,546
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,258,630
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,258,630: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article delves into the details of United States Patent 10,258,630, providing a thorough analysis of its claims, the patent landscape, and relevant data sources.

Overview of the Patent

United States Patent 10,258,630, hereafter referred to as the '630 patent, is a specific example of a patent that can be analyzed using various tools and datasets available from the U.S. Patent and Trademark Office (USPTO) and other sources.

Patent Title and Abstract

To begin, it is essential to identify the title and abstract of the patent, which provide a general overview of the invention. However, specific details of the '630 patent, such as its title and abstract, are not provided in the sources. Typically, this information can be found on the USPTO website or through the Public Search Facility[4].

Claims Analysis

The claims section of a patent is the most critical part, as it defines the scope of the invention. Here are some key points to consider:

Independent and Dependent Claims

  • Independent claims stand alone and define the invention without reference to other claims.
  • Dependent claims refer back to and further limit the independent claims.

For the '630 patent, one would need to review the patent document to identify the number and types of claims, their dependencies, and the specific language used to define the invention.

Claim Scope and Patent Scope Measurements

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including claim-level statistics and document-level statistics. This dataset can be used to analyze the scope of the '630 patent by comparing its claims with those of other patents in the same field[3].

Patent Landscape

Understanding the broader patent landscape is vital for assessing the novelty and non-obviousness of the '630 patent.

Related Patents and Patent Families

Using tools like the Global Dossier service, one can identify related patent applications filed at participating IP Offices. This helps in understanding the patent family and any prior art or office actions related to the '630 patent[4].

Classification and Citation Data

The International Patent Classification (IPC) and the United States Patent Classification (USPC) systems help in categorizing patents. The USPTO's datasets, such as the IPC classification data and USPC classification data, can be used to see how the '630 patent is classified and how it relates to other patents in the same classification[1].

Data Sources and Tools

Several data sources and tools are available for analyzing patents:

PatentsView Database

The PatentsView database offers detailed information on patents, including disambiguated assignee and inventor data, citations, and other relevant metrics. This database can be used to analyze the assignees, inventors, and citations related to the '630 patent[1].

USPTO Economic Working Papers

Documents such as "Patent Claims and Patent Scope" by Marco, Alan C., Sarnoff, Joshua D., and deGrazia, Charles, provide insights into patent scope measurements and trends, which can be applied to the analysis of the '630 patent[3].

Legal and Regulatory Context

Patents are governed by Title 35 of the United States Code. Understanding the legal framework is essential for interpreting the claims and scope of the '630 patent.

Patent Infringement

The '630 patent, like other patents, can be involved in patent infringement cases. For example, the document related to Teva Pharmaceutical Industries Limited involves multiple patents, including the '630 patent, in a civil action for patent infringement[5].

Practical Applications and Implications

  • Competitive Analysis: Analyzing the '630 patent helps in understanding the competitive landscape in the relevant industry.
  • Innovation Tracking: It allows tracking of innovations and trends in the field.
  • Legal Strategies: It informs legal strategies for patent enforcement and defense.

Case Study: Teva Pharmaceutical Industries Limited

The case involving Teva Pharmaceutical Industries Limited and the '630 patent highlights the importance of detailed patent analysis. The lawsuit alleges infringement of one or more claims of the '630 patent, among others. This case demonstrates how the scope and claims of a patent are critical in legal disputes[5].

Key Takeaways

  • Claims Analysis: The claims section is crucial for defining the scope of the invention.
  • Patent Landscape: Understanding related patents and classifications is essential.
  • Data Sources: Utilize databases like PatentsView and USPTO datasets for comprehensive analysis.
  • Legal Context: Familiarize yourself with Title 35 of the United States Code and relevant case law.
  • Practical Applications: Analyzing patents informs competitive strategies, innovation tracking, and legal approaches.

FAQs

What is the primary purpose of the claims section in a patent?

The primary purpose of the claims section is to define the scope of the invention, distinguishing it from prior art and other inventions.

How can I find related patents to the '630 patent?

Use tools like the Global Dossier service and classification data from the USPTO to identify related patent applications and families.

What datasets can I use to analyze the scope of the '630 patent?

The PatentsView database and the USPTO's Patent Claims Research Dataset are valuable resources for analyzing patent claims and scope.

Why is understanding the patent landscape important?

Understanding the patent landscape helps in assessing the novelty and non-obviousness of the invention and informs competitive and legal strategies.

Where can I find detailed information on the '630 patent?

Detailed information can be found on the USPTO website, through the Public Search Facility, or by accessing the patent document directly.

Sources

  1. PatentsView Database: Data Download Tables - PatentsView.
  2. USPTO: U.S. Patent and Trademark Office (USPTO) | USAGov.
  3. USPTO Economic Research: Patent Claims Research Dataset - USPTO.
  4. USPTO Search: Search for patents - USPTO.
  5. Court Document: United States, Title 35 of the United States Code, involving U.S. Patent No. 10,258,630.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,258,630

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mayne Pharma IMVEXXY estradiol INSERT;VAGINAL 208564-001 May 29, 2018 RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF DYSPAREUNIA ⤷  Try for Free
Mayne Pharma IMVEXXY estradiol INSERT;VAGINAL 208564-001 May 29, 2018 RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF A SYMPTOM OF VULVAR AND VAGINAL ATROPHY ⤷  Try for Free
Mayne Pharma IMVEXXY estradiol INSERT;VAGINAL 208564-002 May 29, 2018 RX Yes Yes ⤷  Try for Free ⤷  Try for Free TREATMENT OF DYSPAREUNIA ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,258,630

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2782584 ⤷  Try for Free 301153 Netherlands ⤷  Try for Free
European Patent Office 2782584 ⤷  Try for Free 2021C/558 Belgium ⤷  Try for Free
European Patent Office 2782584 ⤷  Try for Free 122021000080 Germany ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.